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Colloquium C06: Gene Transfer to the Nervous System: From
Basic Mechanisms to Novel Therapeutics
C06-01
Gene therapy for nervous system repair
H. D. Shine
Baylor College of Medicine, Houston, TX, USA
Using experimental models of neurotrauma, several laboratories have demonstra-
ted the efficacy of neurotrophic factors (NFs) to protect neurons from death and to
support axonal regeneration. These observations raised the possibility that NFs
may be effective in treating neurotrauma and neurodegenerative diseases in
humans. However, clinical applications of NFs have been restricted as systemic
delivery of NFs at doses sufficient to reach therapeutic concentrations and to
overcome their short half-lives cause adverse effects. These limitations would be
overcome if NFs were continually expressed at the target site. We tested whether
local expression of NFs would induce axonal regeneration in a model of neural
injury. The cortical spinal tract (CST) in rats was lesioned unilaterally at the level
of the hindbrain and Neurotorphin-3 (NT-3) was expressed locally in the spinal
cord either by retrograde delivery of the vector from the sciatic nerve. Axons were
observed growing from the unlesioned CST across the midline to the denervated
side. Interestingly, axons did not cross the midline if the CST was not lesioned
suggesting that the effect of NT-3 was dependent upon trauma-induced signals.
These data demonstrate that local expression of NFs will induce and support
axonal regeneration in a circumscribed area after injury without adverse effects and
suggest that a therapy based upon this strategy may overcome the limits of
systemic NF delivery for SCI.
Acknowledgements: Supported by NIH grant NS35280 and Mission Connect of
the TIRR Foundation.
C06-02
The neuroimmunology of viral vectors for gene transfer:
a rational approach to neurological gene therapy
P. R. Lowenstein and M. G. Castro
Gene Therapeutics Research Institute, Cedars-Sinai Medical
Center, and David Geffen School of Medicine, University of
California Los Angeles, CA, USA
Vectors, such as adenovirus and lentivirus-derived vectors, are powerful tools to
transfer genes into the brain, for either basic science or therapeutic aim. Various
types of vectors have now been shown to allow up to 12–18 months of stable
transgene expression in the brain. However, injection of viral vectors into the brain
can cause brain inflammation. This inflammation is acute, reversible within
30 days, and unable to inhibit transgene expression. Also, transgene expression
can be ÔeliminatedÕ by the adaptive arm of the immune system, once the immune
system is primed through a systemic immunization protocol. The cellular and
molecular mechanisms of viral vector induced inflammation, as well as the cellular
and molecular mechanisms used by cells of the adaptive immune system to abolish
transgene expression in the brain have not yet been completely elucidated.
Understanding these phenomena is complicated by the so called Ôbrain immune
privilegeÕ. This presentation will discuss the interactions of viral vectors with both
the innate and adaptive immune response, and propose how an understanding of
the basis for the brain’s immune privilege can aid in the development of gene
therapies for brain disorders, both for chronic neurodegeneration, such as
Parkinson’s disease using growth and differentiation factors, or brain tumors,
using immune-stimulatory strategies.
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chronic expression of TNF in the substantia Nigra of
adult mice
F. Pitossi,* N. Di Paolo,* A. Scho¨neberg,  A. Depino,*
C. Chertoff,* C. Ferrari,* K. Pfinzenmaier,  O. Podhajcer*
and U. Eisel 
*Foundation Leloir Institute, CONICET-UBA, Buenos Aires,
Argentina;  Institut fu¨r Zellbiologie und Immunologie, Stuttgart,
Germany
Activation of microglia and induction of cytokines such as Tumor necrosis factor
alpha (TNF) in the substantia nigra (s.n.) have been observed in animal models and
patients with Parkinson’s disease (PD). However, it is unclear whether this
microglial activation could be functional to remove cellular debris after neuronal
death or could be triggering, propagating or delaying the death of dopaminergic
neurons. We have generated conditional knock-in mice in which a TNF transgene
is under the control of the endogenous engrailed promoter (which directs protein
expression mainly to the s.n.). In these mice, constitutive TNF expression is
reduced by an interfering cassette that is flanked by loxP sequences. Injection of
adenoviral vectors expressing CRE (AdCRE) in the s.n. resulted in removal of the
interfering cassette. In addition, s.n.-specific TNF up-regulation was seen in the
AdCRE-injected knock-in mice but not in control animals. Using this combination
of techniques, we showed that while chronic up-regulated TNF expression induced
progressive neuronal loss, lower TNF levels were neuroprotective in the s.n. in the
6-OHDA model of PD. These data suggest a dual role of the chronic expression of
TNF in the s.n. In addition, the progressive neurodegenerative effect of TNF per se
in the s.n. provided us with a new animal model of PD.
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Functional consequences P/Q-type calcium channel
ablation
O. D. Uchitel
Laboratorio de Fisiologı´a y Biologı´a Molecular, Departamento de
Fisiologı´a y Biologı´a Celular y Molecular, Facultad de Ciencias
Exactas y Naturales, Universidad de Buenos Aires, Argentina
P/Q (Cav2.1) calcium channels are expressed throughout central and peripheral
nervous system in most presynaptic terminals where they play a prominent role in
controlling neurotransmitter release. Mutations in the CACNA1A, the gene
encoding the pore-forming a1A subunit of P/Q-type calcium channel, cause a
group of human neurological disorders characterised by ataxia, migraine and/or
epileptiform activity. To understand the consequences of P/Q-type calcium
channels deficiency we studied transmitter release in mice whose a1A subunits
were completely deleted (Jun et al., 1999 PNAS 96, 15,245). As anticipated, P/Q-
type calcium channels were eliminated from whole cell recordings of calcium
currents in cultured chromaffin cells. Alterations in synaptic transmission like
reduction in quantal output, altered synchronisation and lack of short-term
facilitation were present at the neuromuscular junction (Urbano et al., 2001
Biophys. J. 80, 940). This suggests that a1A–/– mice compensate the deficiency of
P/Q-type calcium channels with the over expression of other types of calcium
channels. In an attempt to express P/Q-type calcium channels, we infected a1A–/–
cromaffin cells Ôin vitroÕ and a1A–/– cerebellar cells Ôin vivoÕ with a vector derived
from the herpes simplex virus type-1 containing the transgen of a1A-GFP fusion
protein. The expression of the protein was confirmed by the measurement of GFP
fluorescence.
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